BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38688280)

  • 1. GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignancies.
    Benbarche S; Pineda JMB; Galvis LB; Biswas J; Liu B; Wang E; Zhang Q; Hogg SJ; Lyttle K; Dahi A; Lewis AM; Sarchi M; Rahman J; Fox N; Ai Y; Mehta S; Garippa R; Ortiz-Pacheco J; Li Z; Monetti M; Stanley RF; Doulatov S; Bradley RK; Abdel-Wahab O
    Mol Cell; 2024 May; 84(10):1886-1903.e10. PubMed ID: 38688280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer.
    Zhang J; Huang J; Xu K; Xing P; Huang Y; Liu Z; Tong L; Manley JL
    Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2216712119. PubMed ID: 36459648
    [No Abstract]   [Full Text] [Related]  

  • 3. (G)Patching up mis-splicing in cancer.
    Cieśla M; Bellodi C
    Trends Biochem Sci; 2024 May; ():. PubMed ID: 38762373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer analysis identifies mutations in
    Liu Z; Zhang J; Sun Y; Perea-Chamblee TE; Manley JL; Rabadan R
    Proc Natl Acad Sci U S A; 2020 May; 117(19):10305-10312. PubMed ID: 32332164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1.
    Zhang J; Ali AM; Lieu YK; Liu Z; Gao J; Rabadan R; Raza A; Mukherjee S; Manley JL
    Mol Cell; 2019 Oct; 76(1):82-95.e7. PubMed ID: 31474574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AI-assisted proofreading of RNA splicing.
    Guerra-Moreno Á; Valcárcel J
    Genes Dev; 2023 Dec; 37(21-24):945-947. PubMed ID: 38092520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SF3B1/Hsh155 HEAT motif mutations affect interaction with the spliceosomal ATPase Prp5, resulting in altered branch site selectivity in pre-mRNA splicing.
    Tang Q; Rodriguez-Santiago S; Wang J; Pu J; Yuste A; Gupta V; Moldón A; Xu YZ; Query CC
    Genes Dev; 2016 Dec; 30(24):2710-2723. PubMed ID: 28087715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SF3B1 mutant myelodysplastic syndrome: Recent advances.
    Pellagatti A; Boultwood J
    Adv Biol Regul; 2021 Jan; 79():100776. PubMed ID: 33358369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers.
    Alsafadi S; Dayot S; Tarin M; Houy A; Bellanger D; Cornella M; Wassef M; Waterfall JJ; Lehnert E; Roman-Roman S; Stern MH; Popova T
    Oncogene; 2021 Jan; 40(1):85-96. PubMed ID: 33057152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the SF3B1-SUGP1 interface reveals how numerous cancer mutations cause mRNA missplicing.
    Zhang J; Xie J; Huang J; Liu X; Xu R; Tholen J; Galej WP; Tong L; Manley JL; Liu Z
    Genes Dev; 2023 Dec; 37(21-24):968-983. PubMed ID: 37977822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated mutations in SF3B1 disrupt the interaction between SF3B1 and DDX42.
    Zhao B; Li Z; Qian R; Liu G; Fan M; Liang Z; Hu X; Wan Y
    J Biochem; 2022 Jul; 172(2):117-126. PubMed ID: 35652295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations.
    Choudhary GS; Pellagatti A; Agianian B; Smith MA; Bhagat TD; Gordon-Mitchell S; Sahu S; Pandey S; Shah N; Aluri S; Aggarwal R; Aminov S; Schwartz L; Steeples V; Booher RN; Ramachandra M; Samson M; Carbajal M; Pradhan K; Bowman TV; Pillai MM; Will B; Wickrema A; Shastri A; Bradley RK; Martell RE; Steidl UG; Gavathiotis E; Boultwood J; Starczynowski DT; Verma A
    Elife; 2022 Aug; 11():. PubMed ID: 36040792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability.
    Liberante FG; Lappin K; Barros EM; Vohhodina J; Grebien F; Savage KI; Mills KI
    Sci Rep; 2019 Feb; 9(1):2678. PubMed ID: 30804405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts.
    Mupo A; Seiler M; Sathiaseelan V; Pance A; Yang Y; Agrawal AA; Iorio F; Bautista R; Pacharne S; Tzelepis K; Manes N; Wright P; Papaemmanuil E; Kent DG; Campbell PC; Buonamici S; Bolli N; Vassiliou GS
    Leukemia; 2017 Mar; 31(3):720-727. PubMed ID: 27604819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splicing quality control mediated by DHX15 and its G-patch activator SUGP1.
    Feng Q; Krick K; Chu J; Burge CB
    Cell Rep; 2023 Oct; 42(10):113223. PubMed ID: 37805921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts.
    Moura PL; Mortera-Blanco T; Hofman IJ; Todisco G; Kretzschmar WW; Björklund AC; Creignou M; Hagemann-Jensen M; Ziegenhain C; Cabrerizo Granados D; Barbosa I; Walldin G; Jansson M; Ashley N; Mead AJ; Lundin V; Dimitriou M; Yoshizato T; Woll PS; Ogawa S; Sandberg R; Jacobsen SEW; Hellström-Lindberg E
    Cancer Res; 2024 Jan; 84(2):211-225. PubMed ID: 37921711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splicing factor deficits render hematopoietic stem and progenitor cells sensitive to STAT3 inhibition.
    Potts KS; Cameron RC; Metidji A; Ghazale N; Wallace L; Leal-Cervantes AI; Palumbo R; Barajas JM; Gupta V; Aluri S; Pradhan K; Myers JA; McKinstry M; Bai X; Choudhary GS; Shastri A; Verma A; Obeng EA; Bowman TV
    Cell Rep; 2022 Dec; 41(11):111825. PubMed ID: 36516770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast.
    Carrocci TJ; Zoerner DM; Paulson JC; Hoskins AA
    Nucleic Acids Res; 2017 May; 45(8):4837-4852. PubMed ID: 28062854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the aberrant splicing of MAP3K7 induced by cancer-associated SF3B1 mutation.
    Li Z; Zhao B; Shi Y; Liang Y; Qian R; Wan Y
    J Biochem; 2021 Sep; 170(1):69-77. PubMed ID: 33751071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures.
    Kesarwani AK; Ramirez O; Gupta AK; Yang X; Murthy T; Minella AC; Pillai MM
    Oncogene; 2017 Feb; 36(8):1123-1133. PubMed ID: 27524419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.